MEDP vs SPG · P/E 25, rev $707.3M vs rev $3.55B
Medpace Holdings Inc (MEDP) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
SPG (SPG) common stock.
Latest reported MEDP revenue for 2026-06-30 was $707.3M. Net income was $121.4M. Revenue was up 0.1% from 2026-03-31 to 2026-06-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
MEDP currently screens at market cap $9.30B and trailing P/E 24.7. SPG currently screens at market cap $0.
Not investment advice. Open the MEDP and SPG stock pages for the full models.
Not investment advice.